Bilirubin-new insights into an old molecule

被引:0
作者
Cepelak, Ivana [1 ]
Dodig, Slavica [1 ]
Pavic, Ivan [2 ,3 ]
机构
[1] Univ Zagreb, Fac Pharm & Biochem, Dept Med Biochem & Hematol, Zagreb, Croatia
[2] Univ Childrens Hosp Zagreb, Dept Pulmonol Allergol Immunol & Rheumatol, Zagreb, Croatia
[3] Univ Split, Sch Med, Split, Croatia
关键词
antioxidants; bilirubin; cell signalling; immunomodulation; LOW-DENSITY-LIPOPROTEIN; SERUM BILIRUBIN; UNCONJUGATED BILIRUBIN; CARDIOVASCULAR PROTECTION; GILBERTS-SYNDROME; DISEASE-ACTIVITY; ANTIOXIDANT; RISK; HYPERBILIRUBINEMIA; ACTIVATION;
D O I
10.11613/BM.2025.020501
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
For decades, bilirubin was thought to be merely a degradation product of the hem, a potentially toxic compound and a molecule with no specific physiological function. Recently, it has been discovered that bilirubin has a strong antioxidant effect and possesses molecular signalling, hormonal and immunomodulatory properties. Numerous studies show that moderately elevated serum bilirubin concentrations correlate with a lower risk of developing pathological conditions mediated by oxidative stress and inflammation. Low concentrations within the current reference interval have been shown to be a potential risk factor for various pathological conditions. It is to be expected that knowledge about bilirubin will lead to the determination of bilirubin concentration gaining new importance in diagnostics, for example as a prognostic marker, but also as a therapeutic molecule.
引用
收藏
页码:172 / 185
页数:14
相关论文
共 98 条
[1]   Protective effects of exogenous bilirubin on ischemia-reperfusion injury in the isolated, perfused rat kidney [J].
Adin, CA ;
Croker, BP ;
Agarwal, A .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2005, 288 (04) :F778-F784
[2]   Bilirubin as a Therapeutic Molecule: Challenges and Opportunities [J].
Adin, Christopher A. .
ANTIOXIDANTS, 2021, 10 (10)
[3]   Physiologic Doses of Bilirubin Contribute to Tolerance of Islet Transplants by Suppressing the Innate Immune Response [J].
Adin, Christopher A. ;
VanGundy, Zachary C. ;
Papenfuss, Tracey L. ;
Xu, Feng ;
Ghanem, Mostafa ;
Lakey, Jonathan ;
Hadley, Gregg A. .
CELL TRANSPLANTATION, 2017, 26 (01) :11-21
[4]   The Role of ABC Transporters in Protecting Cells from Bilirubin Toxicity [J].
Bellarosa, C. ;
Bortolussi, G. ;
Tiribelli, C. .
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (25) :2884-2892
[5]   VARIATION OF INITIAL SERUM BILIRUBIN RISE IN NEWBORN-INFANTS WITH TYPE OF ILLNESS [J].
BENARON, DA ;
BOWEN, FW .
LANCET, 1991, 338 (8759) :78-81
[6]   Binding of biliverdin, bilirubin, and thyroid hormones to lipocalin-type prostaglandin D synthase [J].
Beuckmann, CT ;
Aoyagi, M ;
Okazaki, I ;
Hiroike, T ;
Toh, H ;
Hayaishi, O ;
Urade, Y .
BIOCHEMISTRY, 1999, 38 (25) :8006-8013
[7]  
Bilirubin Thomas L., 1998, Clinical laboratory diagnostics. Use and assessment of Clinical Laboratory Results, P192
[8]  
BOSMA PJ, 1994, J BIOL CHEM, V269, P17960
[9]   Bilirubin acts as a multipotent guardian of cardiovascular integrity: more than just a radical idea [J].
Bulmer, Andrew C. ;
Bakrania, Bhavisha ;
Du Toit, Eugene F. ;
Boon, Ai-Ching ;
Clark, Paul J. ;
Powell, Lawrie W. ;
Wagner, Karl-Heinz ;
Headrick, John P. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2018, 315 (03) :H429-H447
[10]   Bilirubin Nanomedicines for the Treatment of Reactive Oxygen Species (ROS)-Mediated Diseases [J].
Chen, Zhejie ;
Vong, Chi Teng ;
Gao, Caifang ;
Chen, Shiyun ;
Wu, Xu ;
Wang, Shengpeng ;
Wang, Yitao .
MOLECULAR PHARMACEUTICS, 2020, 17 (07) :2260-2274